샘플 요청 목록

 카트 문의
시장보고서
상품코드
1757988

자가백신 시장

Autogenous Vaccines
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 266 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 자가백신 시장은 2030년까지 1억 7,340만 달러에 달할 전망

2024년에 1억 4,000만 달러로 추정되는 세계의 자가백신 시장은 2030년에는 1억 7,340만 달러에 달하며, 분석 기간인 2024-2030년의 CAGR은 3.6%로 성장할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 세균주는 CAGR 2.9%를 기록하며, 분석 기간 종료시에는 1억 860만 달러에 달할 것으로 예측됩니다. 바이러스주 부문의 성장률은 분석 기간에 CAGR 4.9%로 추정됩니다.

미국 시장은 3,820만 달러로 추정되는 한편, 중국은 CAGR 6.6%로 성장할 것으로 예측

미국의 자가백신 시장은 2024년에는 3,820만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 분석 기간인 2024-2030년에 CAGR 6.6%로 추이하며, 2030년에는 예측 시장 규모 3,450만 달러에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 1.5%와 2.8%로 예측됩니다. 유럽에서는 독일이 CAGR 2.1%로 성장할 것으로 예측됩니다.

세계의 자가백신 시장 - 주요 동향과 촉진요인 정리

자가백신이 수의학 및 농업 보건 분야에서 전략적 관련성이 높아지는 이유는 무엇인가?

자가백신은 특히 수의학 및 축산 산업에서 지역적, 집단적 감염병을 퇴치하는 데 있으며, 필수적인 요소로 부상하고 있습니다. 광범위하게 사용하도록 개발된 기존 백신과 달리, 자가백신은 특정 농장이나 동물 집단에서 분리된 병원체를 사용하여 조정되어 매우 효과적인 질병 대응책을 제공합니다. 이러한 맞춤형 접근 방식은 상용 백신이 존재하지 않거나 미생물의 변이로 인해 기존 백신이 효과를 잃었을 때 특히 중요합니다. 항균제 내성(AMR)의 확산은 동물의 예방적 건강관리로 전환하는 데 박차를 가하고 있으며, 자가백신이 그 중심적인 역할을 하고 있습니다. 미국, 독일, 프랑스 등의 국가에서는 가축에 대한 항생제 사용을 제한하는 엄격한 규제를 도입하여 감염병을 예방하는 백신에 대한 수요가 증가하고 있습니다. 또한 농가과 수의사들은 생산성 저하, 치료비 증가, 무역 제한 등 가축 질병이 경제적으로 미치는 영향에 대해 점점 더 많이 인식하고 있습니다. 이러한 인식 증가와 자가백신의 국소적 효능과 빠른 예방접종 주기를 실현하는 자가백신의 능력이 결합하여 시장 성장을 주도하고 있습니다.

규제 환경과 동물 의료 인프라는 시장 확대에 어떤 영향을 미치고 있는가?

자가백신의 규제 환경은 크게 변화하고 있으며, USDA Center for Veterinary Biologics(USDA Center for Veterinary Biologics) 및 EMA(European Medicines Agency)와 같은 규제기관은 자가백신의 승인 절차를 간소화하고, 신종 및 유행성 동물 질병에 대처하는 데 있으며, 자가백신의 중요성을 인식하고 있습니다. 이러한 규제 프레임워크는 안전성과 유효성을 보장하는 동시에 시판용 백신에 비해 빠른 시장 진입을 가능하게 하고, 보다 광범위한 사용을 장려하고 있습니다. 또한 아시아태평양과 라틴아메리카를 중심으로 한 신흥 국가 지역의 수의학 인프라가 강화되면서 자가백신 제조업체들에게 새로운 시장이 열리고 있습니다. 브라질과 인도와 같은 국가들은 축산 및 수의학 연구에 많은 투자를 하고 있으며, 이를 통해 이러한 백신의 잠재적 응용 기반을 확대하고 있습니다. 제도적 측면에서는 연구기관, 제약회사, 축산업 협동조합 간의 협력 관계 강화로 새로운 자가 제제 개발이 가속화되고 있습니다. 또한 정부가 지원하는 질병 감시 프로그램을 통해 새롭게 출현하는 병원체를 조기에 발견할 수 있고, 가축군에 특화된 백신을 신속하게 생산할 수 있게 되었습니다. 실제로 규제 당국의 지원, 인프라 개선, 공동 연구 구상의 조합은 시장 확대의 강력한 촉매제 역할을 하고 있습니다.

수요 형성에 있으며, 축산 경제와 바이오 보안은 어떤 역할을 하고 있는가?

가축은 세계 식량안보, 소득 창출 및 무역에서 중요한 역할을 하고 있으며, 특히 인구의 대부분이 축산업에 의존하는 신흥 경제 국가에서 중요한 역할을 하고 있습니다. 가축에 질병이 발생하면 수확량 손실, 수출 금지, 치료비 상승 등 경제적으로 치명적인 영향을 미칠 수 있으므로 농가는 적극적인 질병 예방 전략에 대한 투자를 늘리고 있습니다. 자가백신은 맞춤화 및 신속한 가용성으로 인해 바이오 보안 프로토콜에서 전략적 우위를 점할 수 있습니다. 또한 전 세계에서 집약적 농업의 추세는 질병 전파의 위험을 증가시키고 있으며, 정밀 백신 접종은 필수적인 툴이 되고 있습니다. 육류, 유제품, 가금류 수출이 증가함에 따라 각국은 국제 위생 기준을 충족하고 무역 혼란을 피하기 위해 바이오 보안 조치를 강화하고 있습니다. 다양한 수생 병원체와 다양한 양식장 조건으로 인해 기존 백신으로는 충분하지 않은 경우가 많은 양식업에서도 자가백신이 보급되고 있습니다. 맞춤형 예방접종 솔루션을 통해 건강한 가축군을 유지한다는 경제적 논리가 대규모 농업 관련 기업에게 현장 전용 백신 개발 시설에 대한 투자를 독려하고 있으며, 시장 침투를 더욱 높이고 있습니다. 이처럼 자가백신을 농장 단위의 헬스케어 시스템에 통합하는 것은 선택이 아닌 필수로 자리 잡고 있습니다.

자가백신 시장의 성장은 몇 가지 요인에 의해 주도되고 있습니다.

자가백신 시장의 성장 궤적은 기술적, 농업적, 행동적 변화의 독특한 상호 작용에 의해 촉진되고 있습니다. 주요 원동력 중 하나는 병원체 동정 및 분자진단의 발전으로 자가백신 개발에 소요되는 시간과 비용을 크게 줄였습니다. 농장 기록의 디지털화와 우수한 질병 추적 시스템을 통해 질병 원인 물질의 신속한 분리가 가능해져 신속한 처방이 가능해졌습니다. 둘째, 정밀 축산 증가로 인해 질병 예측 모델링을 기반으로 적시에 백신을 배치할 수 있는 데이터베이스 툴이 보급되고 있습니다. 셋째, 전 세계에서 인수공통전염병이 증가함에 따라 동물에서 사람으로의 감염 위험에 대한 인식이 높아져 농장 단위의 위생 관리가 더욱 엄격해지고 있습니다. 넷째, 대규모 축산 경영에서는 종합적인 가축 위생 계획의 일환으로 개별 백신의 사용을 의무화하는 바이오 보안 프레임워크를 채택하는 경향이 증가하고 있습니다. 다섯째, 무항생제 육류 및 유제품에 대한 소비자의 요구로 인해 생산자는 규정 준수와 제품 무결성을 보장하기 위해 자가백신과 같은 대안을 모색할 수밖에 없습니다. 여섯째, 특히 가금류, 양돈, 양식업 분야에서 확장 가능한 자가백신 제조 플랫폼 개발에 초점을 맞춘 R&D 투자와 민관 파트너십이 눈에 띄게 증가하고 있습니다. 이러한 요인들은 기술, 규제, 소비자 행동에 걸쳐 종합적으로 자가백신 시장의 역동적인 성장을 지원하고 있습니다.

부문

균주 유형(세균주, 바이러스주), 동물 유형(가금, 돼지, 어류, 말, 기타 동물 유형), 최종사용자(수의 연구소 최종사용자, 축산 회사 최종사용자, 동물병원 & 클리닉 최종사용자)

조사 대상 기업의 예(총 32사)

  • ACE Laboratory Services
  • Addison Biological Laboratory
  • AniCon Labor GmbH
  • Boehringer Ingelheim
  • Cambridge Technologies
  • Ceva Sante Animale
  • Deltamune
  • Dyntec s.r.o.
  • Elanco Animal Health
  • Genova Labs
  • HIPRA
  • Huvepharma
  • Hygieia Biological Laboratories
  • Merck Animal Health
  • Newport Laboratories
  • Phibro Animal Health Corporation
  • Sanphar(IPEVE)
  • Vaxxinova
  • Virbac
  • Zoetis Inc.

AI 통합

우리는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.07.15

Global Autogenous Vaccines Market to Reach US$173.4 Million by 2030

The global market for Autogenous Vaccines estimated at US$140.0 Million in the year 2024, is expected to reach US$173.4 Million by 2030, growing at a CAGR of 3.6% over the analysis period 2024-2030. Bacterial Strain, one of the segments analyzed in the report, is expected to record a 2.9% CAGR and reach US$108.6 Million by the end of the analysis period. Growth in the Virus Strain segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$38.2 Million While China is Forecast to Grow at 6.6% CAGR

The Autogenous Vaccines market in the U.S. is estimated at US$38.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$34.5 Million by the year 2030 trailing a CAGR of 6.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.5% and 2.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.1% CAGR.

Global Autogenous Vaccines Market - Key Trends & Drivers Summarized

Why Are Autogenous Vaccines Gaining Strategic Relevance in Veterinary and Agricultural Health?

Autogenous vaccines have emerged as a vital component in the fight against region-specific and herd-specific infections, particularly within the veterinary and livestock industries. Unlike conventional vaccines, which are developed for widespread use, autogenous vaccines are tailored using pathogens isolated from a specific farm or animal population, providing targeted and highly effective disease control. This customized approach is especially crucial in cases where no commercial vaccine exists or where existing vaccines have lost effectiveness due to microbial mutations. The increasing prevalence of antimicrobial resistance (AMR) has also spurred a shift toward preventive healthcare in animals, with autogenous vaccines playing a central role. Countries such as the U.S., Germany, and France have introduced stricter regulations limiting the use of antibiotics in livestock, thereby boosting demand for vaccines that can prevent infections proactively. Moreover, farmers and veterinarians are becoming increasingly aware of the economic impact of animal diseases, including reduced productivity, higher treatment costs, and trade restrictions. This growing awareness, combined with the ability of autogenous vaccines to deliver faster immunization cycles with localized efficacy, is driving the growth of the market.

How Is the Regulatory Environment and Veterinary Healthcare Infrastructure Influencing Market Expansion?

The regulatory landscape for autogenous vaccines is undergoing significant evolution. Regulatory bodies like the USDA Center for Veterinary Biologics and the European Medicines Agency (EMA) have established streamlined approval processes for autogenous vaccines, recognizing their importance in tackling emerging and endemic animal diseases. These regulatory frameworks, while ensuring safety and efficacy, also facilitate quicker market entry compared to commercial vaccines, encouraging more widespread usage. Additionally, the strengthening of veterinary healthcare infrastructure across developing regions, particularly in Asia-Pacific and Latin America, has opened up new markets for autogenous vaccine producers. Countries like Brazil and India are making significant investments in animal husbandry and veterinary research, thereby expanding the potential application base for these vaccines. On the institutional front, increasing collaboration between research institutions, pharmaceutical companies, and livestock cooperatives is accelerating the development of new autogenous formulations. This is further complemented by government-backed disease surveillance programs that help identify emerging pathogens early, enabling faster formulation of herd-specific vaccines. In effect, a combination of regulatory support, improved infrastructure, and cooperative research initiatives is acting as a strong catalyst for market expansion.

What Role Does Livestock Economics and Biosecurity Play in Shaping Demand?

Livestock plays a critical role in global food security, income generation, and trade, especially in developing economies where a significant portion of the population depends on animal agriculture. As disease outbreaks among livestock can have devastating economic consequences-including loss of yield, export bans, and rising treatment costs-farmers are increasingly investing in proactive disease prevention strategies. Autogenous vaccines, by virtue of their customization and faster availability, provide a strategic advantage in biosecurity protocols. Moreover, the global trend toward intensive farming practices has elevated the risk of disease transmission, making precision vaccination an indispensable tool. With growing exports of meat, dairy, and poultry, countries are tightening biosecurity measures to meet international health standards and avoid trade disruptions. Autogenous vaccines are also becoming popular in aquaculture, where traditional vaccines often fall short due to diverse aquatic pathogens and varying farm conditions. The economic logic of maintaining healthy herds through tailored immunization solutions is prompting larger agribusinesses to invest in dedicated on-site vaccine development facilities, further increasing market penetration. Thus, the integration of autogenous vaccines into farm-level health management systems is becoming more of a necessity than an option.

The Growth in the Autogenous Vaccines Market Is Driven by Several Factors…

The market's upward trajectory is fueled by a unique interplay of technological, agricultural, and behavioral shifts. One of the primary drivers is the advancement in pathogen identification and molecular diagnostics, which has significantly reduced the time and cost of developing autogenous vaccines. The digitization of farm records and better disease tracking systems enable faster isolation of disease-causing agents, facilitating rapid formulation. Secondly, the rising trend of precision livestock farming has led to the widespread use of data-driven tools that can inform timely vaccine deployment based on predictive disease modeling. Third, the global rise in zoonotic disease outbreaks has heightened awareness about animal-to-human transmission risks, incentivizing stricter farm-level health controls. Fourth, large-scale animal farming operations are increasingly adopting biosecurity frameworks that mandate the use of customized vaccines as part of comprehensive herd health plans. Fifth, consumer demand for antibiotic-free meat and dairy products has compelled producers to seek alternatives such as autogenous vaccines to ensure both compliance and product integrity. Sixth, there is a marked increase in R&D investments and public-private partnerships focused on developing scalable autogenous vaccine manufacturing platforms, especially for poultry, swine, and aquaculture sectors. These factors, converging across technology, regulation, and consumer behavior, collectively underpin the dynamic growth of the autogenous vaccines market.

SCOPE OF STUDY:

The report analyzes the Autogenous Vaccines market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Strain Type (Bacterial Strain, Virus Strain); Animal Type (Poultry, Swine, Fish, Horses, Other Animal Types); End-Use (Veterinary Research Institutes End-Use, Livestock Farming Companies End-Use, Veterinary Clinics & Hospitals End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 32 Featured) -

  • ACE Laboratory Services
  • Addison Biological Laboratory
  • AniCon Labor GmbH
  • Boehringer Ingelheim
  • Cambridge Technologies
  • Ceva Sante Animale
  • Deltamune
  • Dyntec s.r.o.
  • Elanco Animal Health
  • Genova Labs
  • HIPRA
  • Huvepharma
  • Hygieia Biological Laboratories
  • Merck Animal Health
  • Newport Laboratories
  • Phibro Animal Health Corporation
  • Sanphar (IPEVE)
  • Vaxxinova
  • Virbac
  • Zoetis Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Autogenous Vaccines - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Surge in Zoonotic and Livestock Diseases Generates Demand for Custom Vaccines
    • Shift Toward Precision Veterinary Medicine Strengthens Business Case for Autogenous Vaccines
    • Rising Restrictions on Antibiotics in Animal Husbandry Drive Adoption of Vaccination Programs
    • Growing Awareness of Animal Health and Biosecurity Measures Spurs Market Growth
    • Increasing Regulatory Acceptance for Custom Formulations Expands Market Opportunity
    • Rise in Aquaculture and Poultry Farming Drives Vaccine Usage in Intensive Farming Systems
    • Growing Threat of Antimicrobial Resistance (AMR) Promotes Preventive Veterinary Care
    • Expansion of Livestock Production in Emerging Economies Drives Adoption of Tailored Vaccines
    • Emergence of Specialized Contract Manufacturing Organizations (CMOs) Supports Market Scalability
    • Government Support for Veterinary Health Infrastructure Spurs Demand for Custom Vaccination
    • Ethical and Regulatory Pressures on Large-Scale Antibiotic Use Fuel Market Momentum
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Autogenous Vaccines Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Autogenous Vaccines by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Autogenous Vaccines by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Bacterial Strain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Bacterial Strain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Virus Strain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Virus Strain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Veterinary Clinics & Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Veterinary Clinics & Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Veterinary Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Veterinary Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Livestock Farming Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Livestock Farming Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Poultry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Poultry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Swine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Swine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Fish by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Fish by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Horses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Horses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Other Animal Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Other Animal Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Autogenous Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 24: USA Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 28: USA Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 29: USA 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • CANADA
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 34: Canada Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Canada 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • JAPAN
    • Autogenous Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Japan 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 40: Japan Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Japan 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • CHINA
    • Autogenous Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 42: China Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 43: China 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 46: China Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 47: China 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • EUROPE
    • Autogenous Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Autogenous Vaccines by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 49: Europe 6-Year Perspective for Autogenous Vaccines by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 52: Europe Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Europe 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • FRANCE
    • Autogenous Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 58: France Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 59: France 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 60: France Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 61: France 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • GERMANY
    • Autogenous Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 64: Germany Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Germany 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 66: Germany Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Germany 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 70: Italy Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Italy 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 72: Italy Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Italy 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • UNITED KINGDOM
    • Autogenous Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 76: UK Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 77: UK 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 78: UK Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 79: UK 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 82: Spain Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Spain 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 84: Spain Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Spain 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 88: Russia Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Russia 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 90: Russia Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Russia 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 94: Rest of Europe Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Rest of Europe 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 96: Rest of Europe Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Rest of Europe 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Autogenous Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Autogenous Vaccines by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific 6-Year Perspective for Autogenous Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2025 & 2030
    • TABLE 100: Asia-Pacific Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Asia-Pacific 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 102: Asia-Pacific Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Asia-Pacific 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • AUSTRALIA
    • Autogenous Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 106: Australia Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Australia 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 108: Australia Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Australia 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • INDIA
    • Autogenous Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 112: India Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 113: India 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 114: India Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 115: India 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • SOUTH KOREA
    • TABLE 118: South Korea Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 119: South Korea 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 120: South Korea Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 121: South Korea 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 124: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of Asia-Pacific 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 126: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • LATIN AMERICA
    • Autogenous Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 130: Latin America Recent Past, Current & Future Analysis for Autogenous Vaccines by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 131: Latin America 6-Year Perspective for Autogenous Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2025 & 2030
    • TABLE 132: Latin America Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Latin America 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 136: Latin America Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 137: Latin America 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • ARGENTINA
    • TABLE 138: Argentina Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 139: Argentina 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 142: Argentina Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 143: Argentina 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • BRAZIL
    • TABLE 144: Brazil Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 145: Brazil 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 148: Brazil Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 149: Brazil 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • MEXICO
    • TABLE 150: Mexico Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 151: Mexico 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 154: Mexico Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 155: Mexico 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 156: Rest of Latin America Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 157: Rest of Latin America 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 160: Rest of Latin America Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 161: Rest of Latin America 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • MIDDLE EAST
    • Autogenous Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 162: Middle East Recent Past, Current & Future Analysis for Autogenous Vaccines by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 163: Middle East 6-Year Perspective for Autogenous Vaccines by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 166: Middle East Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 167: Middle East 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 168: Middle East Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 169: Middle East 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 172: Iran Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 173: Iran 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 174: Iran Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 175: Iran 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 178: Israel Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 179: Israel 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 180: Israel Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 181: Israel 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 184: Saudi Arabia Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 185: Saudi Arabia 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 186: Saudi Arabia Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 187: Saudi Arabia 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 190: UAE Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 191: UAE 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 192: UAE Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 193: UAE 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 196: Rest of Middle East Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 197: Rest of Middle East 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 198: Rest of Middle East Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 199: Rest of Middle East 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030
  • AFRICA
    • Autogenous Vaccines Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Autogenous Vaccines by Strain Type - Bacterial Strain and Virus Strain - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa 6-Year Perspective for Autogenous Vaccines by Strain Type - Percentage Breakdown of Value Sales for Bacterial Strain and Virus Strain for the Years 2025 & 2030
    • TABLE 202: Africa Recent Past, Current & Future Analysis for Autogenous Vaccines by End-Use - Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 203: Africa 6-Year Perspective for Autogenous Vaccines by End-Use - Percentage Breakdown of Value Sales for Veterinary Clinics & Hospitals End-Use, Veterinary Research Institutes End-Use and Livestock Farming Companies End-Use for the Years 2025 & 2030
    • TABLE 204: Africa Recent Past, Current & Future Analysis for Autogenous Vaccines by Animal Type - Poultry, Swine, Fish, Horses and Other Animal Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 205: Africa 6-Year Perspective for Autogenous Vaccines by Animal Type - Percentage Breakdown of Value Sales for Poultry, Swine, Fish, Horses and Other Animal Types for the Years 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제